Cargando…
Recent Advances in the Development of Peptide Vaccines and Their Delivery Systems against Group A Streptococcus
Group A Streptococcus (GAS) infection can cause a variety of diseases in humans, ranging from common sore throats and skin infections, to more invasive diseases and life-threatening post-infectious diseases, such as rheumatic fever and rheumatic heart disease. Although research has been ongoing sinc...
Autores principales: | Azuar, Armira, Jin, Wanli, Mukaida, Saori, Hussein, Waleed M., Toth, Istvan, Skwarczynski, Mariusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789462/ https://www.ncbi.nlm.nih.gov/pubmed/31266253 http://dx.doi.org/10.3390/vaccines7030058 |
Ejemplares similares
-
Cell-Penetrating Peptides-Based Liposomal Delivery System Enhanced Immunogenicity of Peptide-Based Vaccine against Group A Streptococcus
por: Yang, Jieru, et al.
Publicado: (2021) -
Development of Polyelectrolyte Complexes for the Delivery of Peptide-Based Subunit Vaccines against Group A Streptococcus
por: Zhao, Lili, et al.
Publicado: (2020) -
Poly(hydrophobic Amino Acids) and Liposomes for Delivery of Vaccine against Group A Streptococcus
por: Azuar, Armira, et al.
Publicado: (2022) -
Development of Multilayer Nanoparticles for the Delivery of Peptide-Based Subunit Vaccine against Group A Streptococcus
por: Kiong, Jolynn, et al.
Publicado: (2022) -
Polyacrylate–Peptide Antigen Conjugate as a Single-Dose Oral Vaccine against Group A Streptococcus
por: Faruck, Mohammad Omer, et al.
Publicado: (2020)